CURE Pharmaceutical Competitors and Similar CompaniesClear all
CURE Pharmaceutical's competitors and similar companies include CSL Behring, Biogen, Livzon Pharmaceutical Group and Cadila Pharmaceuticals.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | |||
Founding Date | Founding Date 2011 | Founding Date 1904 | Founding Date 1978 | Founding Date 1985 | Founding Date 1951 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Oxnard, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | |
Employees | Employees 15 | Employees 7,5692% decrease | Employees 7,605 | Employees 9,067 | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 104.7 m | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $4.3m (FY, 2023) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.2m (FY, 2023) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $3.1m (FY, 2023) | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A |
Net income | Net income ($3.4m) (FY, 2023) | Net income N/A | Net income $1.3b (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Trademark Applications | Trademark Applications N/A | Trademark Applications 1 (Dec, 2020) | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications N/A |
Trademarks | Trademarks N/A | Trademarks 4 (Dec, 2020) | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company